{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T20:28:44Z","timestamp":1785270524327,"version":"3.55.0"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T00:00:00Z","timestamp":1736899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T00:00:00Z","timestamp":1736899200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["DA048613"],"award-info":[{"award-number":["DA048613"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["Z1A AA000355"],"award-info":[{"award-number":["Z1A AA000355"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["DA056410"],"award-info":[{"award-number":["DA056410"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1038\/s41380-024-02881-2","type":"journal-article","created":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T14:19:03Z","timestamp":1736950743000},"page":"2718-2728","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Cannabidiol abrogates cue-induced anxiety associated with normalization of mitochondria-specific transcripts and linoleic acid in the nucleus accumbens shell"],"prefix":"10.1038","volume":"30","author":[{"given":"Jacqueline-Marie N.","family":"Ferland","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Chisholm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmina","family":"Abdalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8597-7253","authenticated-orcid":false,"given":"Resat","family":"Cinar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9557-9307","authenticated-orcid":false,"given":"Clare","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather B.","family":"Bradshaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0808-2832","authenticated-orcid":false,"given":"Yasmin L.","family":"Hurd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,15]]},"reference":[{"key":"2881_CR1","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1016\/S0140-6736(18)30136-3","volume":"391","author":"EA Thiele","year":"2018","unstructured":"Thiele EA, Marsh ED, French JA, Mazurkiewicz-Beldzinska M, Benbadis SR, Joshi C, et al. Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet. 2018;391:1085\u201396.","journal-title":"Lancet"},{"key":"2881_CR2","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1111\/epi.14628","volume":"60","author":"O Devinsky","year":"2019","unstructured":"Devinsky O, Nabbout R, Miller I, Laux L, Zolnowska M, Wright S, et al. Long-term cannabidiol treatment in patients with Dravet syndrome: an open-label extension trial. Epilepsia. 2019;60:294\u2013302.","journal-title":"Epilepsia"},{"key":"2881_CR3","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1523\/JNEUROSCI.2416-19.2020","volume":"40","author":"TG Freels","year":"2020","unstructured":"Freels TG, Baxter-Potter LN, Lugo JM, Glodosky NC, Wright HR, Baglot SL, et al. Vaporized cannabis extracts have reinforcing properties and support conditioned drug-seeking behavior in rats. J Neurosci. 2020;40:1897\u2013908.","journal-title":"J Neurosci"},{"key":"2881_CR4","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1038\/npp.2015.367","volume":"41","author":"M Haney","year":"2016","unstructured":"Haney M, Malcolm RJ, Babalonis S, Nuzzo PA, Cooper ZD, Bedi G, et al. Oral cannabidiol does not alter the subjective, reinforcing or cardiovascular effects of smoked cannabis. Neuropsychopharmacology. 2016;41:1974\u201382.","journal-title":"Neuropsychopharmacology"},{"key":"2881_CR5","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/s41401-018-0032-8","volume":"40","author":"A Viudez-Martinez","year":"2019","unstructured":"Viudez-Martinez A, Garcia-Gutierrez MS, Medrano-Relinque J, Navarron CM, Navarrete F, Manzanares J. Cannabidiol does not display drug abuse potential in mice behavior. Acta Pharmacol Sin. 2019;40:358\u201364.","journal-title":"Acta Pharmacol Sin"},{"key":"2881_CR6","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.2174\/1570159X21666230322143401","volume":"21","author":"G Madeo","year":"2023","unstructured":"Madeo G, Kapoor A, Giorgetti R, Busardo FP, Carlier J. Update on Cannabidiol Clinical Toxicity and Adverse Effects: A Systematic Review. Curr Neuropharmacol. 2023;21:2323\u201342.","journal-title":"Curr Neuropharmacol"},{"key":"2881_CR7","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/S2215-0366(19)30401-8","volume":"6","author":"N Black","year":"2019","unstructured":"Black N, Stockings E, Campbell G, Tran LT, Zagic D, Hall WD, et al. Cannabinoids for the treatment of mental disorders and symptoms of mental disorders: a systematic review and meta-analysis. Lancet Psychiatry. 2019;6:995\u20131010.","journal-title":"Lancet Psychiatry"},{"key":"2881_CR8","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1111\/cts.13425","volume":"16","author":"JC Arnold","year":"2023","unstructured":"Arnold JC, McCartney D, Suraev A, McGregor IS. The safety and efficacy of low oral doses of cannabidiol: An evaluation of the evidence. Clin Transl Sci. 2023;16:10\u201330.","journal-title":"Clin Transl Sci"},{"key":"2881_CR9","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s40429-022-00450-7","volume":"9","author":"SD Lichenstein","year":"2022","unstructured":"Lichenstein SD. THC, CBD, and Anxiety: A review of recent findings on the anxiolytic and anxiogenic effects of cannabis\u2019 primary cannabinoids. Curr Addict Rep. 2022;9:473\u201385.","journal-title":"Curr Addict Rep"},{"key":"2881_CR10","doi-asserted-by":"publisher","unstructured":"Leen-Feldner EW, Bynion TM, Eglit GM, Bonn-Miller MO, Gournay LR, Feldner MT. A double-blind, randomized, placebo-controlled test of the effects of cannabidiol on fear elicited by a 10% carbon dioxide-enriched air breathing challenge. Psychopharmacology 2022. https:\/\/doi.org\/10.1007\/s00213-022-06258-7","DOI":"10.1007\/s00213-022-06258-7"},{"key":"2881_CR11","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1177\/02698811221124792","volume":"36","author":"CM Kwee","year":"2022","unstructured":"Kwee CM, van Gerven JM, Bongaerts FL, Cath DC, Jacobs G, Baas JM, et al. Cannabidiol in clinical and preclinical anxiety research. A systematic review into concentration-effect relations using the IB-de-risk tool. J Psychopharmacol. 2022;36:1299\u2013314.","journal-title":"J Psychopharmacol"},{"key":"2881_CR12","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.euroneuro.2023.04.001","volume":"72","author":"CMB Kwee","year":"2023","unstructured":"Kwee CMB, Leen NA, Van der Kamp RC, Van Lissa CJ, Cath DC, Groenink L, et al. Anxiolytic effects of endocannabinoid enhancing compounds: A systematic review and meta-analysis. Eur Neuropsychopharmacol. 2023;72:79\u201394.","journal-title":"Eur Neuropsychopharmacol"},{"key":"2881_CR13","doi-asserted-by":"publisher","first-page":"3242","DOI":"10.1111\/bph.13724","volume":"174","author":"JLC Lee","year":"2017","unstructured":"Lee JLC, Bertoglio LJ, Guimaraes FS, Stevenson CW. Cannabidiol regulation of emotion and emotional memory processing: relevance for treating anxiety-related and substance abuse disorders. Br J Pharmacol. 2017;174:3242\u201356.","journal-title":"Br J Pharmacol"},{"key":"2881_CR14","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.pbb.2012.10.008","volume":"103","author":"LD O\u2019Brien","year":"2013","unstructured":"O\u2019Brien LD, Wills KL, Segsworth B, Dashney B, Rock EM, Limebeer CL, et al. Effect of chronic exposure to rimonabant and phytocannabinoids on anxiety-like behavior and saccharin palatability. Pharmacol Biochem Behav. 2013;103:597\u2013602.","journal-title":"Pharmacol Biochem Behav"},{"key":"2881_CR15","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1007\/s00213-017-4626-5","volume":"234","author":"EM Rock","year":"2017","unstructured":"Rock EM, Limebeer CL, Petrie GN, Williams LA, Mechoulam R, Parker LA. Effect of prior foot shock stress and Delta(9)-tetrahydrocannabinol, cannabidiolic acid, and cannabidiol on anxiety-like responding in the light-dark emergence test in rats. Psychopharmacology. 2017;234:2207\u201317.","journal-title":"Psychopharmacology"},{"key":"2881_CR16","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/S2215-0366(20)30290-X","volume":"7","author":"TP Freeman","year":"2020","unstructured":"Freeman TP, Hindocha C, Baio G, Shaban NDC, Thomas EM, Astbury D, et al. Cannabidiol for the treatment of cannabis use disorder: a phase 2a, double-blind, placebo-controlled, randomised, adaptive Bayesian trial. Lancet Psychiatry. 2020;7:865\u201374.","journal-title":"Lancet Psychiatry"},{"key":"2881_CR17","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1176\/appi.ajp.2019.18101191","volume":"176","author":"YL Hurd","year":"2019","unstructured":"Hurd YL, Spriggs S, Alishayev J, Winkel G, Gurgov K, Kudrich C, et al. Cannabidiol for the reduction of cue-induced craving and anxiety in drug-abstinent individuals with heroin use disorder: a double-blind randomized placebo-controlled trial. Am J Psychiatry. 2019;176:911\u201322.","journal-title":"Am J Psychiatry"},{"key":"2881_CR18","doi-asserted-by":"publisher","first-page":"14764","DOI":"10.1523\/JNEUROSCI.4291-09.2009","volume":"29","author":"Y Ren","year":"2009","unstructured":"Ren Y, Whittard J, Higuera-Matas A, Morris CV, Hurd YL. Cannabidiol, a nonpsychotropic component of cannabis, inhibits cue-induced heroin seeking and normalizes discrete mesolimbic neuronal disturbances. J Neurosci. 2009;29:14764\u20139.","journal-title":"J Neurosci"},{"key":"2881_CR19","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.1038\/s41386-018-0050-8","volume":"43","author":"G Gonzalez-Cuevas","year":"2018","unstructured":"Gonzalez-Cuevas G, Martin-Fardon R, Kerr TM, Stouffer DG, Parsons LH, Hammell DC, et al. Unique treatment potential of cannabidiol for the prevention of relapse to drug use: preclinical proof of principle. Neuropsychopharmacology. 2018;43:2036\u201345.","journal-title":"Neuropsychopharmacology"},{"key":"2881_CR20","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.tins.2016.12.006","volume":"40","author":"YL Hurd","year":"2017","unstructured":"Hurd YL. Cannabidiol: swinging the marijuana pendulum from \u2018weed\u2019 to medication to treat the opioid epidemic. Trends Neurosci. 2017;40:124\u20137.","journal-title":"Trends Neurosci"},{"key":"2881_CR21","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1089\/can.2021.0050","volume":"7","author":"HM Harris","year":"2022","unstructured":"Harris HM, Gul W, ElSohly MA, Sufka KJ. Differential effects of cannabidiol and a novel cannabidiol analog on oxycodone place preference and analgesia in mice: an opioid abuse deterrent with analgesic properties. Cannabis Cannabinoid Res. 2022;7:804\u201313.","journal-title":"Cannabis Cannabinoid Res"},{"key":"2881_CR22","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.neuropharm.2018.09.043","volume":"143","author":"MA Lujan","year":"2018","unstructured":"Lujan MA, Castro-Zavala A, Alegre-Zurano L, Valverde O. Repeated Cannabidiol treatment reduces cocaine intake and modulates neural proliferation and CB1R expression in the mouse hippocampus. Neuropharmacology. 2018;143:163\u201375.","journal-title":"Neuropharmacology"},{"key":"2881_CR23","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1177\/0269881116667706","volume":"31","author":"A Mahmud","year":"2017","unstructured":"Mahmud A, Gallant S, Sedki F, D\u2019Cunha T, Shalev U. Effects of an acute cannabidiol treatment on cocaine self-administration and cue-induced cocaine seeking in male rats. J Psychopharmacol. 2017;31:96\u2013104.","journal-title":"J Psychopharmacol"},{"key":"2881_CR24","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1007\/s00213-004-1825-7","volume":"175","author":"LA Parker","year":"2004","unstructured":"Parker LA, Burton P, Sorge RE, Yakiwchuk C, Mechoulam R. Effect of low doses of delta9-tetrahydrocannabinol and cannabidiol on the extinction of cocaine-induced and amphetamine-induced conditioned place preference learning in rats. Psychopharmacology. 2004;175:360\u20136.","journal-title":"Psychopharmacology"},{"key":"2881_CR25","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1055\/s-0043-117838","volume":"84","author":"JR Markos","year":"2018","unstructured":"Markos JR, Harris HM, Gul W, ElSohly MA, Sufka KJ. Effects of cannabidiol on morphine conditioned place preference in mice. Planta Med. 2018;84:221\u20134.","journal-title":"Planta Med"},{"key":"2881_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2023.105196","volume":"150","author":"PW Kalivas","year":"2023","unstructured":"Kalivas PW, Gourley SL, Paulus MP. Intrusive thinking: Circuit and synaptic mechanisms of a transdiagnostic psychiatric symptom. Neurosci Biobehav Rev. 2023;150:105196.","journal-title":"Neurosci Biobehav Rev"},{"key":"2881_CR27","doi-asserted-by":"publisher","unstructured":"Mlost J, Bryk M, Starowicz K. Cannabidiol for pain treatment: focus on pharmacology and mechanism of action. Int. J. Mol. Sci. 2020;21:8870. https:\/\/doi.org\/10.3390\/ijms21228870","DOI":"10.3390\/ijms21228870"},{"key":"2881_CR28","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1248\/bpb.19.1109","volume":"19","author":"K Watanabe","year":"1996","unstructured":"Watanabe K, Kayano Y, Matsunaga T, Yamamoto I, Yoshimura H. Inhibition of anandamide amidase activity in mouse brain microsomes by cannabinoids. Biol Pharm Bull. 1996;19:1109\u201311.","journal-title":"Biol Pharm Bull"},{"key":"2881_CR29","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1111\/j.1476-5381.2010.01166.x","volume":"163","author":"L De Petrocellis","year":"2011","unstructured":"De Petrocellis L, Ligresti A, Moriello AS, Allara M, Bisogno T, Petrosino S, et al. Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes. Br J Pharmacol. 2011;163:1479\u201394.","journal-title":"Br J Pharmacol"},{"key":"2881_CR30","doi-asserted-by":"publisher","first-page":"8711","DOI":"10.1074\/jbc.M114.618447","volume":"290","author":"MW Elmes","year":"2015","unstructured":"Elmes MW, Kaczocha M, Berger WT, Leung K, Ralph BP, Wang L, et al. Fatty acid-binding proteins (FABPs) are intracellular carriers for Delta9-tetrahydrocannabinol (THC) and cannabidiol (CBD). J Biol Chem. 2015;290:8711\u201321.","journal-title":"J Biol Chem"},{"key":"2881_CR31","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1089\/can.2018.0031","volume":"3","author":"E Leishman","year":"2018","unstructured":"Leishman E, Manchanda M, Thelen R, Miller S, Mackie K, Bradshaw HB. Cannabidiol\u2019s Upregulation of N-acyl Ethanolamines in the central nervous system requires N-acyl phosphatidyl ethanolamine-specific phospholipase D. Cannabis Cannabinoid Res. 2018;3:228\u201341.","journal-title":"Cannabis Cannabinoid Res"},{"key":"2881_CR32","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.phrs.2016.04.020","volume":"110","author":"E Leishman","year":"2016","unstructured":"Leishman E, Cornett B, Spork K, Straiker A, Mackie K, Bradshaw HB. Broad impact of deleting endogenous cannabinoid hydrolyzing enzymes and the CB1 cannabinoid receptor on the endogenous cannabinoid-related lipidome in eight regions of the mouse brain. Pharmacol Res. 2016;110:159\u201372.","journal-title":"Pharmacol Res"},{"key":"2881_CR33","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41582-019-0284-z","volume":"16","author":"L Cristino","year":"2020","unstructured":"Cristino L, Bisogno T, Di Marzo V. Cannabinoids and the expanded endocannabinoid system in neurological disorders. Nat Rev Neurol. 2020;16:9\u201329.","journal-title":"Nat Rev Neurol"},{"key":"2881_CR34","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.conb.2020.02.002","volume":"64","author":"JPH Verharen","year":"2020","unstructured":"Verharen JPH, Zhu Y, Lammel S. Aversion hot spots in the dopamine system. Curr Opin Neurobiol. 2020;64:46\u201352.","journal-title":"Curr Opin Neurobiol"},{"key":"2881_CR35","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.biopsych.2021.09.017","volume":"92","author":"RJ Ellis","year":"2022","unstructured":"Ellis RJ, Bara A, Vargas CA, Frick AL, Loh E, Landry J, et al. Prenatal Delta(9)-tetrahydrocannabinol exposure in males leads to motivational disturbances related to striatal epigenetic dysregulation. Biol Psychiatry. 2022;92:127\u201338.","journal-title":"Biol Psychiatry"},{"key":"2881_CR36","doi-asserted-by":"publisher","first-page":"2583","DOI":"10.1038\/s41380-022-01467-0","volume":"28","author":"JN Ferland","year":"2023","unstructured":"Ferland JN, Ellis RJ, Rompala G, Landry JA, Callens JE, Ly A, et al. Dose mediates the protracted effects of adolescent THC exposure on reward and stress reactivity in males relevant to perturbation of the basolateral amygdala transcriptome. Mol Psychiatry. 2023;28:2583\u201393.","journal-title":"Mol Psychiatry"},{"key":"2881_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550.","journal-title":"Genome Biol"},{"key":"2881_CR38","doi-asserted-by":"publisher","first-page":"W90","DOI":"10.1093\/nar\/gkw377","volume":"44","author":"MV Kuleshov","year":"2016","unstructured":"Kuleshov MV, Jones MR, Rouillard AD, Fernandez NF, Duan Q, Wang Z, et al. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res. 2016;44:W90\u201397.","journal-title":"Nucleic Acids Res"},{"key":"2881_CR39","doi-asserted-by":"publisher","first-page":"e1004574","DOI":"10.1371\/journal.pcbi.1004574","volume":"11","author":"WM Song","year":"2015","unstructured":"Song WM, Zhang B. Multiscale embedded gene co-expression network analysis. PLoS Comput Biol. 2015;11:e1004574.","journal-title":"PLoS Comput Biol"},{"key":"2881_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-9-559","volume":"9","author":"P Langfelder","year":"2008","unstructured":"Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinform. 2008;9:559.","journal-title":"BMC Bioinform"},{"key":"2881_CR41","doi-asserted-by":"crossref","unstructured":"Johnson CT, de Abreu GHD, Mackie K, Lu HC, Bradshaw HB Cannabinoids accumulate in mouse breast milk and differentially regulate lipid composition and lipid signaling molecules involved in infant development. BBA Adv 2022; 2:100054.","DOI":"10.1016\/j.bbadva.2022.100054"},{"key":"2881_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.ynstr.2019.100191","volume":"11","author":"N Daviu","year":"2019","unstructured":"Daviu N, Bruchas MR, Moghaddam B, Sandi C, Beyeler A. Neurobiological links between stress and anxiety. Neurobiol Stress. 2019;11:100191.","journal-title":"Neurobiol Stress"},{"key":"2881_CR43","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/nn.4275","volume":"19","author":"SL Gourley","year":"2016","unstructured":"Gourley SL, Taylor JR. Going and stopping: Dichotomies in behavioral control by the prefrontal cortex. Nat Neurosci. 2016;19:656\u201364.","journal-title":"Nat Neurosci"},{"key":"2881_CR44","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1016\/S0024-3205(98)00052-6","volume":"62","author":"K Watanabe","year":"1998","unstructured":"Watanabe K, Ogi H, Nakamura S, Kayano Y, Matsunaga T, Yoshimura H, et al. Distribution and characterization of anandamide amidohydrolase in mouse brain and liver. Life Sci. 1998;62:1223\u20139.","journal-title":"Life Sci"},{"key":"2881_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.plefa.2021.102366","volume":"175","author":"JS Hamilton","year":"2021","unstructured":"Hamilton JS, Klett EL. Linoleic acid and the regulation of glucose homeostasis: A review of the evidence. Prostaglandins Leukot Essent Fatty Acids. 2021;175:102366.","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"2881_CR46","doi-asserted-by":"publisher","first-page":"3470","DOI":"10.1523\/JNEUROSCI.1331-14.2015","volume":"35","author":"F Ramirez","year":"2015","unstructured":"Ramirez F, Moscarello JM, LeDoux JE, Sears RM. Active avoidance requires a serial basal amygdala to nucleus accumbens shell circuit. J Neurosci. 2015;35:3470\u20137.","journal-title":"J Neurosci"},{"key":"2881_CR47","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/nn2061","volume":"11","author":"SM Reynolds","year":"2008","unstructured":"Reynolds SM, Berridge KC. Emotional environments retune the valence of appetitive versus fearful functions in nucleus accumbens. Nat Neurosci. 2008;11:423\u20135.","journal-title":"Nat Neurosci"},{"key":"2881_CR48","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1101\/lm.1798810","volume":"17","author":"LA Bradfield","year":"2010","unstructured":"Bradfield LA, McNally GP. The role of nucleus accumbens shell in learning about neutral versus excitatory stimuli during Pavlovian fear conditioning. Learn Mem. 2010;17:337\u201343.","journal-title":"Learn Mem"},{"key":"2881_CR49","doi-asserted-by":"publisher","first-page":"15779","DOI":"10.1523\/JNEUROSCI.3557-12.2012","volume":"32","author":"A Badrinarayan","year":"2012","unstructured":"Badrinarayan A, Wescott SA, Vander Weele CM, Saunders BT, Couturier BE, Maren S, et al. Aversive stimuli differentially modulate real-time dopamine transmission dynamics within the nucleus accumbens core and shell. J Neurosci. 2012;32:15779\u201390.","journal-title":"J Neurosci"},{"key":"2881_CR50","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.neuron.2018.11.005","volume":"101","author":"JW de Jong","year":"2019","unstructured":"de Jong JW, Afjei SA, Pollak Dorocic I, Peck JR, Liu C, Kim CK, et al. A neural circuit mechanism for encoding aversive stimuli in the mesolimbic dopamine system. Neuron. 2019;101:133\u2013151.e137.","journal-title":"Neuron"},{"key":"2881_CR51","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/S0893-133X(00)00208-6","volume":"24","author":"JL Madrigal","year":"2001","unstructured":"Madrigal JL, Olivenza R, Moro MA, Lizasoain I, Lorenzo P, Rodrigo J, et al. Glutathione depletion, lipid peroxidation and mitochondrial dysfunction are induced by chronic stress in rat brain. Neuropsychopharmacology. 2001;24:420\u20139.","journal-title":"Neuropsychopharmacology"},{"key":"2881_CR52","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1097\/PSY.0000000000000545","volume":"80","author":"M Picard","year":"2018","unstructured":"Picard M, McEwen BS. Psychological stress and mitochondria: a systematic review. Psychosom Med. 2018;80:141\u201353.","journal-title":"Psychosom Med"},{"key":"2881_CR53","doi-asserted-by":"publisher","first-page":"15486","DOI":"10.1073\/pnas.1512653112","volume":"112","author":"F Hollis","year":"2015","unstructured":"Hollis F, van der Kooij MA, Zanoletti O, Lozano L, Canto C, Sandi C. Mitochondrial function in the brain links anxiety with social subordination. Proc Natl Acad Sci USA. 2015;112:15486\u201391.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2881_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.112776","volume":"42","author":"S Ghosal","year":"2023","unstructured":"Ghosal S, Gebara E, Ramos-Fernandez E, Chioino A, Grosse J, Guillot de Suduiraut I, et al. Mitofusin-2 in nucleus accumbens D2-MSNs regulates social dominance and neuronal function. Cell Rep. 2023;42:112776.","journal-title":"Cell Rep"},{"key":"2881_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2022.106603","volume":"187","author":"RF Malheiro","year":"2023","unstructured":"Malheiro RF, Carmo H, Carvalho F, Silva JP. Cannabinoid-mediated targeting of mitochondria on the modulation of mitochondrial function and dynamics. Pharmacol Res. 2023;187:106603.","journal-title":"Pharmacol Res"},{"key":"2881_CR56","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1523\/JNEUROSCI.4212-08.2009","volume":"29","author":"D Ryan","year":"2009","unstructured":"Ryan D, Drysdale AJ, Lafourcade C, Pertwee RG, Platt B. Cannabidiol targets mitochondria to regulate intracellular Ca2+ levels. J Neurosci. 2009;29:2053\u201363.","journal-title":"J Neurosci"},{"key":"2881_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2020.112627","volume":"388","author":"AJ Sales","year":"2020","unstructured":"Sales AJ, Guimaraes FS, Joca SRL. CBD modulates DNA methylation in the prefrontal cortex and hippocampus of mice exposed to forced swim. Behav Brain Res. 2020;388:112627.","journal-title":"Behav Brain Res"},{"key":"2881_CR58","first-page":"283","volume":"8","author":"CD Drummond-Main","year":"2023","unstructured":"Drummond-Main CD, Ahn Y, Kesler M, Gavrilovici C, Kim DY, Kiroski I, et al. Cannabidiol Impairs Brain Mitochondrial Metabolism and Neuronal Integrity. Cannabis Cannabinoid Res. 2023;8:283\u201398.","journal-title":"Cannabis Cannabinoid Res"},{"key":"2881_CR59","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/0014-5793(95)01173-C","volume":"375","author":"SC Bondy","year":"1995","unstructured":"Bondy SC, Marwah S. Stimulation of synaptosomal free radical production by fatty acids: relation to esterification and to degree of unsaturation. FEBS Lett. 1995;375:53\u20135.","journal-title":"FEBS Lett"},{"key":"2881_CR60","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1111\/jnc.14818","volume":"152","author":"M Hennebelle","year":"2020","unstructured":"Hennebelle M, Morgan RK, Sethi S, Zhang Z, Chen H, Grodzki AC, et al. Linoleic acid-derived metabolites constitute the majority of oxylipins in the rat pup brain and stimulate axonal growth in primary rat cortical neuron-glia co-cultures in a sex-dependent manner. J Neurochem. 2020;152:195\u2013207.","journal-title":"J Neurochem"},{"key":"2881_CR61","doi-asserted-by":"crossref","unstructured":"Norman JE, Nuthikattu S, Milenkovic D, Rutledge JC, Villablanca AC. Sex-specific response of the brain free oxylipin profile to soluble epoxide hydrolase inhibition. Nutrients 2023; 15:1214.","DOI":"10.3390\/nu15051214"},{"key":"2881_CR62","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1016\/S0002-9440(10)63787-X","volume":"164","author":"JK Reddy","year":"2004","unstructured":"Reddy JK. Peroxisome proliferators and peroxisome proliferator-activated receptor alpha: biotic and xenobiotic sensing. Am J Pathol. 2004;164:2305\u201321.","journal-title":"Am J Pathol"},{"key":"2881_CR63","doi-asserted-by":"publisher","first-page":"2803","DOI":"10.2174\/0929867321666140303143455","volume":"21","author":"M Fidaleo","year":"2014","unstructured":"Fidaleo M, Fanelli F, Ceru MP, Moreno S. Neuroprotective properties of peroxisome proliferator-activated receptor alpha (PPARalpha) and its lipid ligands. Curr Med Chem. 2014;21:2803\u201321.","journal-title":"Curr Med Chem"},{"key":"2881_CR64","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.freeradbiomed.2016.06.023","volume":"100","author":"JC Corona","year":"2016","unstructured":"Corona JC, Duchen MR. PPARgamma as a therapeutic target to rescue mitochondrial function in neurological disease. Free Radic Biol Med. 2016;100:153\u201363.","journal-title":"Free Radic Biol Med"},{"key":"2881_CR65","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.4103\/1673-5374.165313","volume":"10","author":"S Moreno","year":"2015","unstructured":"Moreno S, Ceru MP. In search for novel strategies towards neuroprotection and neuroregeneration: is PPARalpha a promising therapeutic target? Neural Regen Res. 2015;10:1409\u201312.","journal-title":"Neural Regen Res"},{"key":"2881_CR66","doi-asserted-by":"publisher","first-page":"e64541","DOI":"10.1371\/journal.pone.0064541","volume":"8","author":"M Puligheddu","year":"2013","unstructured":"Puligheddu M, Pillolla G, Melis M, Lecca S, Marrosu F, De Montis MG, et al. PPAR-alpha agonists as novel antiepileptic drugs: preclinical findings. PLoS ONE. 2013;8:e64541.","journal-title":"PLoS ONE"},{"key":"2881_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2023.154771","volume":"114","author":"S Khosropoor","year":"2023","unstructured":"Khosropoor S, Alavi MS, Etemad L, Roohbakhsh A. Cannabidiol goes nuclear: The role of PPARgamma. Phytomedicine. 2023;114:154771.","journal-title":"Phytomedicine"},{"key":"2881_CR68","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.plipres.2018.04.003","volume":"70","author":"V Fernandes","year":"2018","unstructured":"Fernandes V, Teles K, Ribeiro C, Treptow W, Santos G. Fat nucleosome: Role of lipids on chromatin. Prog Lipid Res. 2018;70:29\u201334.","journal-title":"Prog Lipid Res"},{"key":"2881_CR69","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.863","volume":"12","author":"X Wang","year":"2022","unstructured":"Wang X, Han X, Powell CA. Lipids and genes: Regulatory roles of lipids in RNA expression. Clin Transl Med. 2022;12:e863.","journal-title":"Clin Transl Med"},{"key":"2881_CR70","doi-asserted-by":"crossref","unstructured":"Melas PA, Scherma M, Fratta W, Cifani C, Fadda P Cannabidiol as a Potential Treatment for Anxiety and Mood Disorders: Molecular Targets and Epigenetic Insights from Preclinical Research. Int J Mol Sci 2021; 22:1863.","DOI":"10.3390\/ijms22041863"},{"key":"2881_CR71","doi-asserted-by":"publisher","first-page":"142","DOI":"10.2174\/1871524920666200924114524","volume":"21","author":"JC Pastrana-Trejo","year":"2021","unstructured":"Pastrana-Trejo JC, Duarte-Ake F, Us-Camas R, De-la-Pena C, Parker L, Pertwee RG, et al. Effects on the Post-translational Modification of H3K4Me3, H3K9ac, H3K9Me2, H3K27Me3, and H3K36Me2 levels in cerebral cortex, hypothalamus and pons of rats after a systemic administration of cannabidiol: a preliminary study. Cent Nerv Syst Agents Med Chem. 2021;21:142\u20137.","journal-title":"Cent Nerv Syst Agents Med Chem"},{"key":"2881_CR72","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.euroneuro.2008.07.001","volume":"18","author":"RM Bitencourt","year":"2008","unstructured":"Bitencourt RM, Pamplona FA, Takahashi RN. Facilitation of contextual fear memory extinction and anti-anxiogenic effects of AM404 and cannabidiol in conditioned rats. Eur Neuropsychopharmacol. 2008;18:849\u201359.","journal-title":"Eur Neuropsychopharmacol"},{"key":"2881_CR73","doi-asserted-by":"crossref","unstructured":"Barnes RC, Banjara S, McHann MC, Almodovar S, Henderson-Redmond AN, Morgan DJ et al. Assessing dose and sex dependent antinociceptive effects of cannabidiol and amitriptyline, alone and in combination, and exploring mechanism of action involving serotonin 1A receptors. J Pharmacol Exp Ther 2023.","DOI":"10.1124\/jpet.123.001855"},{"key":"2881_CR74","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1097\/01.ftd.0000177223.19294.5c","volume":"27","author":"T Nadulski","year":"2005","unstructured":"Nadulski T, Pragst F, Weinberg G, Roser P, Schnelle M, Fronk EM, et al. Randomized, double-blind, placebo-controlled study about the effects of cannabidiol (CBD) on the pharmacokinetics of Delta9-tetrahydrocannabinol (THC) after oral application of THC verses standardized cannabis extract. Ther Drug Monit. 2005;27:799\u2013810.","journal-title":"Ther Drug Monit"},{"key":"2881_CR75","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2023.114793","volume":"459","author":"ALF Arantes","year":"2023","unstructured":"Arantes ALF, Carvalho MC, Brandao ML, Prado WA, Crippa JAS, Lovick TA, et al. Antinociceptive action of cannabidiol on thermal sensitivity and post-operative pain in male and female rats. Behav Brain Res. 2023;459:114793.","journal-title":"Behav Brain Res"},{"key":"2881_CR76","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2023.114663","volume":"455","author":"PM Hernandes","year":"2023","unstructured":"Hernandes PM, Batistela MF, Nascimento-Silva JM, Frias AT, Matthiesen M, Campos AC, et al. Sex and estrous cycle-linked differences in the effect of cannabidiol on panic-like responding in rats and mice. Behav Brain Res. 2023;455:114663.","journal-title":"Behav Brain Res"}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41380-024-02881-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-024-02881-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-024-02881-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T10:06:55Z","timestamp":1747735615000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41380-024-02881-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,15]]},"references-count":76,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["2881"],"URL":"https:\/\/doi.org\/10.1038\/s41380-024-02881-2","relation":{},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,15]]},"assertion":[{"value":"17 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}